In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sangamo Therapeutics Inc.

www.sangamo.com

Latest From Sangamo Therapeutics Inc.

UniQure Aiming To Be First With Hemophilia B Gene Therapy

The company has come a long way since gene therapy flop Glybera, and claims best-in-class status for viral vector.

Research & Development Blood & Coagulation Disorders

Hemophilia A Gene Therapy: BioMarin In Lead, Sangamo ‘Prays’ For Superior Results

Gene therapy could transform hemophilia treatment, but competition is intense

Gene Therapy FDA

BioMarin’s Momentum Grows With Twin Blockbuster Plans

The frontrunner in hemophilia A gene therapy has been hit by data doubts, but this and achondroplasia drug could deliver in 2020.

Clinical Trials FDA

Novo Nordisk, Bluebird Targeting ‘Lifelong’ Gene Therapies

Novo Nordisk and bluebird bio will jointly develop genome editing treatments for genetic diseases, beginning with hemophilia.
Commercial Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Sangamo Therapeutics Inc.
  • Senior Management
  • Sandy Macrae, PhD, Pres. & CEO
    Sung Lee, EVP, CFO
    Bettina M Cockroft, MD, SVP, CMO
  • Contact Info
  • Sangamo Therapeutics Inc.
    Phone: (510) 970-6000
    501 Canal Blvd.
    #A
    Richmond, CA 94804
    USA
UsernamePublicRestriction

Register